These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24702965)

  • 1. Selections of reality: applying Burke's dramatism to a harm reduction program.
    Järvinen M; Miller G
    Int J Drug Policy; 2014 Sep; 25(5):879-87. PubMed ID: 24702965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The network of Centres for the Prevention and Treatment of Drug Addiction in the Republic of Slovenia.
    Kastelic A; Rihtar TK
    Med Arh; 2001; 55(3):135-9. PubMed ID: 11769426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The making of the chronic addict.
    Järvinen M; Andersen D
    Subst Use Misuse; 2009; 44(6):865-85. PubMed ID: 19444727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is low threshold methadone maintenance treatment?
    Strike C; Millson M; Hopkins S; Smith C
    Int J Drug Policy; 2013 Nov; 24(6):e51-6. PubMed ID: 23743178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring and evaluation of the Hungarian methadone maintenance programmes].
    Rácz J; Melles K; Márványkövi F; Vadász V
    Psychiatr Hung; 2010; 25(3):202-20. PubMed ID: 20884995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective.
    Johnson B; Richert T
    J Psychoactive Drugs; 2014; 46(5):427-35. PubMed ID: 25364995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone, a contested substance: Danish methadone policy in the 1970s.
    Houborg E
    Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national study of the retention of Irish opiate users in methadone substitution treatment.
    Mullen L; Barry J; Long J; Keenan E; Mulholland D; Grogan L; Delargy I
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):551-8. PubMed ID: 22747484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with methadone treatment among injection drug users in Bangkok, Thailand.
    Fairbairn N; Hayashi K; Kaplan K; Suwannawong P; Qi J; Wood E; Kerr T
    J Subst Abuse Treat; 2012 Jul; 43(1):108-13. PubMed ID: 22154035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing attitudes and beliefs of staff working in methadone maintenance programs.
    Caplehorn RM; Lumley TS; Irwig L; Saunders JB
    Aust N Z J Public Health; 1998 Jun; 22(4):505-8. PubMed ID: 9659781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of provision of opioid substitution therapy provision in Tijuana, Mexico.
    Burgos JL; Cepeda JA; Kahn JG; Mittal ML; Meza E; Lazos RRP; Vargas PC; Vickerman P; Strathdee SA; Martin NK
    Harm Reduct J; 2018 May; 15(1):28. PubMed ID: 29792191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
    Trigg BG; Dickman SL
    Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
    White WL
    J Addict Dis; 2012; 31(3):199-206. PubMed ID: 22873182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
    Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M
    Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A satisfaction survey of opioid-dependent patients with methadone maintenance treatment.
    Aziz Z; Chong NJ
    J Subst Abuse Treat; 2015 Jun; 53():47-51. PubMed ID: 25616750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.